Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
0.6212
-0.0397 (-6.01%)
At close: Nov 13, 2026, 4:00 PM EST
0.6212
0.00 (0.00%)
After-hours: Nov 13, 2026, 4:00 PM EST
Dermata Therapeutics Employees
Dermata Therapeutics had 9 employees as of December 31, 2025. The number of employees increased by 1 or 12.50% compared to the previous year. That makes Dermata Therapeutics the 40,504th largest employer in the world and 6,102nd in the United States.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
$8,237
Profits / Employee
-$1,055,340
Market Cap
2.50M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 9 | 1 | 12.50% |
| Dec 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 8 | 0 | - |
| Dec 31, 2021 | 8 | 1 | 14.29% |
| Mar 31, 2021 | 7 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aptevo Therapeutics | 33 |
| Calidi Biotherapeutics | 29 |
| Curis | 24 |
| Azitra | 13 |
| Ernexa Therapeutics | 7 |
| Traws Pharma | 7 |
| Eocene | 6 |
| KALA BIO | 6 |
DRMA News
- 3 days ago - Dermata Therapeutics Quarterly report: Q3 2026 - Filings
- 3 days ago - Dermata Therapeutics Earnings release: Q3 2026 - Filings
- 15 days ago - Dermata initiates acne clinical trial of second Tome skincare product - TheFly
- 4 weeks ago - Dermata announces results from study evaluating Tome Foundational Treatment - TheFly
- 4 weeks ago - Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment - Accesswire
- 5 weeks ago - Dermata Therapeutics registers to sell 6.92M shares of common stock for holders - TheFly
- 5 weeks ago - Dermata Therapeutics Registration statement: Registration filing - Filings
- 2 months ago - Dermata Therapeutics announces commercial launch of Tome Foundational Treatment - TheFly